CSR Program: Improving Access to Care for Women | Takeda Pharmaceuticals
Improving access to sustainable, women-centered care for hard-to-reach women and girls
Building comprehensive sexual and reproductive health services by strengthening workforce capacity, health systems and community support mechanisms
The Program
Partner: Ipas
Budget: 999 million yen
Term: 4 years
Launch: 2022
Area: Ethiopia, Indonesia, Pakistan
Visit the Ipas website
Women and girls in some of the world’s most remote, fragile, and otherwise hard-to-reach areas often lack access to quality sexual and reproductive health (SRH) care which can lead to unintended pregnancies, death and injuries from unsafe abortions, and other potential loss of educational and economic opportunities. This program aims to improve access to and use of comprehensive sexual and reproductive health services for hard-to-reach women and girls in Ethiopia, Indonesia and Pakistan by integrating clinical training and mentorships that are grounded in women-centered care principles.
Photo Credit: Richard Lord for Ipas
Have more questions?
Contact us if you'd like more information about our Global CSR Program.
Banner Image Credit: Ipas Pakistan